Related Experiment Video
Updated: May 14, 2026

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
Published on: November 29, 2019
Serum albumin: accuracy and clinical use
Ilenia Infusino1, Mauro Panteghini
1Centre for Metrological Traceability in Laboratory Medicine (CIRME), University of Milan, Milan, Italy. infusino.ilenia@hsacco.it
Accurate serum albumin measurement is crucial for disease prognosis. Current methods often have high uncertainty, compromising patient care, especially with non-specific assays.
Area of Science:
- Clinical chemistry
- Laboratory medicine
- Biochemical analysis
Background:
- Albumin is a key plasma protein for prognostic assessment in various diseases.
- Clinical guidelines mandate serum albumin monitoring with assay-independent cut-offs.
- Standardization requires accurate and equivalent results across different commercial methods.
Purpose of the Study:
- To evaluate the adequacy of current albumin measurement traceability and uncertainty budgets.
- To assess if established quality levels for albumin measurement can be met.
- To determine if current methods guarantee clinical accuracy for patient management.
Main Methods:
- Analysis of the albumin traceability chain and associated uncertainty budgets.
- Evaluation of analytical goals derived from biologic variation.
- Comparison of measurement uncertainty with established quality levels.
Main Results:
- Current albumin measurement uncertainty budgets are likely too high to meet quality standards.
- Traceability chains may not provide sufficient accuracy for clinical usefulness.
- Non-specific colorimetric methods introduce additional random uncertainty.
Conclusions:
- Existing albumin measurement systems may not ensure the required accuracy for reliable patient management.
- Improvements in standardization and reduction of measurement uncertainty are needed.
- Specific, standardized methods are preferable to non-specific colorimetric assays.
Related Concept Videos
Serum Studies: Renal Function Tests
Nephrotic Syndrome II : Assessment and Medical Management
Drug Distribution: Plasma Protein Binding
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Nephrotic Syndrome I : Introduction